Post

Epetraborole Phase III enrolment pause sets back NTM late-stage pipeline

AN2 Therapeutics recently announced its decision to voluntarily pause enrollment of the Phase III portion of its Phase II/III EBO-301 …

SeaStar’s device granted humanitarian exemption approval for children with AKI

Following positive clinical results, the US Food Drug Administration (FDA) has granted SeaStar Medical a humanitarian device exemption (HDE) approval …

Novartis will see modest boost to blood cancer portfolio with MorphoSys acquisition

On 4 February 2024, Novartis announced its acquisition of the prominent biopharmaceutical company MorphoSys AG. This deal provides Novartis with …

EVŌQ Nano’s antimicrobial platform proves effective against HAIs

US-based nanoscience company EVŌQ Nano’s antimicrobial medical device platform has demonstrated effectiveness against the world's leading pathogens implicated in healthcare-associated …

Magentiq’s AI-aided colonoscopy tool increases adenoma detection by 7%

Israel-based Magentiq Eye has published data from a clinical trial assessing its computer-aided detection colonoscopy tool, Magentiq-Colo CADe. The results …